Cargando…
Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control
BACKGROUND: To address the infectious disease (ID) and substance use disorder (SUD) syndemic, we developed an integrated ID/SUD clinical team rooted in harm reduction at a county hospital in Miami, Florida. The Severe Injection-Related Infection (SIRI) team treats people who inject drugs (PWID) and...
Autores principales: | Serota, David P, Rosenbloom, Liza, Hervera, Belén, Seo, Grace, Feaster, Daniel J, Metsch, Lisa R, Suarez, Edward, Chueng, Teresa A, Hernandez, Salma, Rodriguez, Allan E, Tookes, Hansel E, Doblecki-Lewis, Susanne, Bartholomew, Tyler S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830545/ https://www.ncbi.nlm.nih.gov/pubmed/36632415 http://dx.doi.org/10.1093/ofid/ofac688 |
Ejemplares similares
-
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study
por: Hervera, Belén, et al.
Publicado: (2023) -
Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016–2017
por: Serota, David P, et al.
Publicado: (2020) -
Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team
por: Serota, David P., et al.
Publicado: (2021) -
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
por: Bartholomew, Tyler S., et al.
Publicado: (2022) -
Impact of routine opt-out HIV/HCV screening on testing uptake at a syringe services program: An interrupted time series analysis
por: Bartholomew, Tyler S., et al.
Publicado: (2020)